GLP-1 drugs are creating new business opportunities
With a total understanding of the science, the consumers and the sectors, Ipsos can help your business ask the right questions about GLP-1s — and find the right answers.
In this webinar, Ipsos will frame the latest dealmaking trends using recent transactions and market data, followed by a moderated discussion with active investors on what is changing in valuation, deal structures, and decision criteria, and what this means for pharma acquirers and innovator biotechs preparing for partnering conversations.
![[WEBINAR] Dealmaking 2026: What’s Changing, What’s Not, and How to Position for the Next Wave](/sites/default/files/styles/list_item_image/public/ct/event/2026-03/deal.png?itok=NtU1lGCc)
